- Rapid antimicrobial susceptibility testing not superior for 30-day outcomes.
- No difference in time to effective therapy.
- Faster antibiotic adjustment with rapid antimicrobial susceptibility testing.
- No differences in mortality or other outcomes.
- Potential benefit in resistant infection subgroups.
Source: JAMA